U.S.-CHINA PHARMA: Shrewd Strategies for Mining Profits from Pharma Opportunities in China

 

Based on 0 rating(s)

Address

Martin Conference Center at Harvard Medical School
77 Avenue Louis Pasteur

Description

  Join U.S.-CHINA PHARMA and meet face-to-face with hundreds of visionaries who are shaping the future R&D landscape between the United States and China. Compare and explore different discovery operations and approaches, and learn about best practices and strategies in leveraging partnerships, alliances, collaborations, outsourcing, and in-licensing to bring a drug from bench to clinic cheaper and faster. Join today and walk away with partners for your next project.
Hot Topics for 2011: • Identify R&D strategies to cost-effectively expand product portfolios • New approaches to feed R&D pipelines through academic/industry partnerships  • Clinical and translational strategies in the area of biomarker research • Emerging business models for R&D partnerships and their impact on the pharmaceutical and biotech industries • Role of technology transfer and licensing, and assess potential investment opportunities  • Suitable entities for preclinical and clinical outsourcing
Prices and discounts
Your Registration Fee Covers:

• Unlimited access to all workshops, presentations, and panel discussions
• Networking events including receptions or dinners during the conference
• Admission to the exhibition area
• Breakfast, lunch, and refreshments
• On-site materials

 Pricing  Book and Pay by
 12/15/10  Book and Pay by
 3/16/11  Book and Pay by
 5/18/11  Standard Price  Regular Admission  (SAVE $400)
 $1,299  (SAVE $300)
 $1,399  (SAVE $200)
 $1,499  $1,699  Academic
 Government,
 NGOs  (SAVE $250)
 $625  (SAVE $150)
 $725  (SAVE $50)
 $825  $875

*Payments must be made before the cut-off date in order to receive any discounts.
Please read our conference registration terms and conditions.

 

More Information

Visit organizer's website